文献速递白血病

IKZF1缺失与UKALL遗传学分类对按NOPHO 2008方案治疗的儿童B细胞前体急性淋巴细胞白血病的预后影响

The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols.
PubMed 文献 · Br J Haematol · 2023-05-08

研究纳入390例按NOPHO ALL 2008方案治疗的儿童B细胞前体急性淋巴细胞白血病(BCP-ALL)患者,分析包括IKZF1在内的8个不良预后相关基因座拷贝数改变(CNA)及其与细胞遗传学信息联合的预后影响。结果显示IKZF1缺失或不良风险CNA谱与全队列不良结局相关,在标危组中IKZF1缺失者无复发生存概率(pRFS)和总生存概率(pOS)均更差(p≤0.001);B-other患者中IKZF1缺失者pRFS为60% vs 90%、pOS为65% vs 89%。多变量分析校正包括可测量残留病在内的已知危险因素后,IKZF1缺失和不良风险CNA谱均为复发和死亡的独立因素。

要点

  • IKZF1缺失或不良风险CNA谱与全队列不良结局相关。
  • 标危组中IKZF1缺失者pRFS和pOS均更差(p≤0.001)。
  • B-other患者中IKZF1缺失者pRFS 60% vs 90%、pOS 65% vs 89%。

核心结论

  • 具有高危CNA或IKZF1缺失的BCP-ALL患者 despite otherwise low-risk features 预后更差。
  • 同时具有良好CNA和细胞遗传学特征的患者在全队列及各风险组中无复发生存和总生存均更优(p≤0.001)。
  • 研究结果提示CNA评估有望优化ALL的危险分层。

研究设计与样本

  • 研究纳入390例按NOPHO ALL 2008方案治疗的儿童B细胞前体急性淋巴细胞白血病(BCP-ALL)患者。
  • 分析8个与不良预后相关基因座(包括IKZF1)的拷贝数改变(CNA)。
  • 分别评估各基因座单独、组合为CNA谱以及与细胞遗传学信息联合对结局的影响。

主要发现

  • IKZF1缺失或不良风险CNA谱的存在与全队列不良结局相关。
  • 标危组中IKZF1缺失病例的无复发生存概率(pRFS)更差(p≤0.001),总生存概率(pOS)也更差(p≤0.001)。
  • B-other患者中IKZF1缺失与较差pRFS相关(60% vs 90%)和较差pOS相关(65% vs 89%)。
  • 多变量分析校正包括可测量残留病在内的已知危险因素后,IKZF1缺失和不良风险CNA谱均为复发和死亡的独立因素。
  • 同时具有良好CNA和细胞遗传学特征的患者在全队列及各风险组中无复发生存(p≤0.001)和总生存(p≤0.001)均更优。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated 390 paediatric B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) patients treated according to NOPHO ALL 2008, regarding copy number alterations (CNA) of eight loci associated with adverse prognosis, including IKZF1. The impact on outcome was investigated for each locus individually, combined as CNA profiles and together with cytogenetic information. The presence of IKZF1 deletion or a poor-risk CNA profile was associated with poor outcome in the whole cohort. In the standard-risk group, IKZF1-deleted cases had an inferior probability of relapse-free survival (pRFS) (p ≤ 0.001) and overall survival (pOS) (p ≤ 0.001). Additionally, among B-other patients, IKZF1 deletion correlated with poor pRFS (60% vs. 90%) and pOS (65% vs. 89%). Both IKZF1 deletion and a poor-risk CNA profile were independent factors for relapse and death in multivariable analyses adjusting for known risk factors including measurable residual disease. Our data indicate that BCP-ALL patients with high-risk CNA or IKZF1 deletion have worse prognosis despite otherwise low-risk features. Conversely, patients with both a good CNA and cytogenetic profile had a superior relapse-free (p ≤ 0.001) and overall survival (p ≤ 0.001) in the cohort, across all risk groups. Taken together, our findings highlight the potential of CNA assessment to refine stratification in ALL.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Öfverholm I, Rezayee F, Heyman M, et al. The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols. Br J Haematol. 2023. PMID: 37156607. doi:10.1111/bjh.18852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。